Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HemmaMed Oy
OY
Dissolved
Y-tunnus 3312765-7
Lapinlahdenkatu 16
Other human health activities n.e.c. · NACE 8699
Est. 2022
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 357K
+195% vs 2023
EBITDA margin
-7.2%
-1479% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
EUR -28K
-6854% vs 2023
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 357K
+195%
EBITDA
EUR -26K
-1479%
Net profit
EUR -28K
-6854%
Total assets
EUR 103K
+127%
Equity
EUR 59K
+389%
Employees
2
—
Company information
Legal name
HemmaMed Oy
Y-tunnus number
3312765-7
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
15. syyskuuta 2022
Share capital
EUR 0
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialan on kaikki laillinen liiketoiminta.
Contact
Address
Lapinlahdenkatu 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
EUR thousands
Item
2023
2024
Revenue
121
357
Staff expenses
−5
−42
EBITDA
2
−26
Depreciation & amort.
−2
−3
EBIT
−0
−28
Net financials
−0
−0
Profit before tax
−0
−28
Tax
−0
0
Net profit
−0
−28
Balance sheet
EUR thousands
Item
2023
2024
Total assets
45
103
Equity
12
59
Long-term debt
0
0
Short-term debt
17
44
Total debt
17
44
Financial ratios
5-year trend
EBITDA margin
-7.2%
This company
15.8%
Market median
-146% vs market
2023
2024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
2023
2024
Return on equity
-47.4%
This company
18.4%
Market median
-358% vs market
2023
2024
Net profit margin
-7.9%
This company
8.1%
Market median
-198% vs market
2023
2024
Asset turnover
3.47×
This company
1.12×
Market median
+210% vs market
2023
2024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TN
Tom Niklas Karlberg
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
SO
Sten Olof Felix Olsson
Board of Directors
2022
JM
Jeanette Margareth Kortman-Blom
Board of Directors
2022
LH
Lars Hannes Relander
Board of Directors
2024
OI
Otto Ivar Johan Lindberg
Board of Directors
2022
Former (1)
RG
Robert Gustav Bergholm
Board of Directors
2025 – 2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of HemmaMed Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Tom Niklas Karlberg
Chief Executive Officer
0 companies
Sten Olof Felix Olsson
Board of Directors
0 companies
Robert Gustav Bergholm
Board of Directors
0 companies
Jeanette Margareth Kortman-Blom
Board of Directors
0 companies
Lars Hannes Relander
Board of Directors
0 companies
Otto Ivar Johan Lindberg
Board of Directors
0 companies